Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis-Reference-Cited by-同舟云学术

Integrative omics analysis identifies biomarkers of idiopathic pulmonary fibrosis

Published:2022-01 Issue:1 Volume:79 Page:
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Zheng Peiyan,Sun Shixue,Wang Jingxian,Cheng Zhangkai Jason,Lei Kuan Cheok,Xue Mingshan,Zhang Teng,Huang Huimin,Zhang Xiaohua Douglas,Sun Baoqing^ORCID

Funder

national natural science foundation of china

bureau of traditional chinese medicine scientific research project of guangdong

the first affiliated hospital of guangzhou medical university

guangzhou institute of respiratory health open project

the university of macau

the science and technology development fund, macau sar

non-profit central research institute fund of chinese academy of medical sciences

Zhongnanshan Medical Foundation of Guangdong Province

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00018-021-04094-0.pdf

Reference83 articles.

1. Meyer KC, Nathan SD (2019) Idiopathic pulmonary fibrosis. Humana Press, Cham

2. Lawson WE, Grant SW, Ambrosini V, Womble KE, Dawson EP, Lane KB et al (2004) Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 59:977–980. https://doi.org/10.1136/thx.2004.026336

3. Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL et al (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84:52–59. https://doi.org/10.1016/j.ajhg.2008.11.010

4. Kropski JA, Blackwell TS, Loyd JE (2015) The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J 45:1717–1727. https://doi.org/10.1183/09031936.00163814

5. Kaur A, Mathai SK, Schwartz DA (2017) Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment. Front Med (Lausanne) 4:154. https://doi.org/10.3389/fmed.2017.00154

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction;Chinese Medical Journal Pulmonary and Critical Care Medicine;2024-06

2. The mechanism of action of Botrychium (Thunb.) Sw. for prevention of idiopathic pulmonary fibrosis based on 1H-NMR-based metabolomics;Journal of Pharmacy and Pharmacology;2024-05-22

3. Research advances of MAL family members in tumorigenesis and tumor progression (Review);Molecular Medicine Reports;2024-02-14

4. Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information;Scientific Reports;2024-01-15

5. Integration of Multi-Omics Data for the Classification of Glioma Types and Identification of Novel Biomarkers;Bioinformatics and Biology Insights;2024-01